AAAAAA
Results:
1-7
|
Results: 7
Authors:
de Bont, ESJM
Guikema, JEJ
Scherpen, F
Meeuwsen, T
Kamps, WA
Vellenga, E
Bos, NA
Citation: Esjm. De Bont et al., Mobilized human CD34+hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma, CANCER RES, 61(20), 2001, pp. 7654-7659
Authors:
de Bont, ESJM
Nijhuis, CO
Kamps, WA
Vellenga, E
Citation: Esjm. De Bont et al., Interpretation of inflammatory markers in feverish cancer patients with orwithout neutropenia at admission, BR J HAEM, 114(2), 2001, pp. 489-490
Authors:
de Bont, ESJM
Rosati, S
Jacobs, S
Kamps, WA
Vellenga, E
Citation: Esjm. De Bont et al., Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor, BR J HAEM, 113(2), 2001, pp. 296-304
Authors:
de Bont, ESJM
Kimpen, JLL
Tamminga, RYJ
Niemarkt, AE
de Leilj, LHMF
Kamps, WA
Citation: Esjm. De Bont et al., Intrinsic capacity of monocytes to produce cytokines ex vivo in patients with acute lymphoblastic leukaemia, CYTOKINE, 12(11), 2000, pp. 1723-1726
Procalcitonin: A diagnostic marker of bacterial infection in neutropenic cancer patients with fever?
Authors:
de Bont, ESJM
Vellenga, E
Swaanenburg, J
Kamps, W
Citation: Esjm. De Bont et al., Procalcitonin: A diagnostic marker of bacterial infection in neutropenic cancer patients with fever?, INFECTION, 28(6), 2000, pp. 398-400
Authors:
de Bont, ESJM
Reilly, CR
Lo, D
Glimcher, LH
Laufer, TM
Citation: Esjm. De Bont et al., A minimal level of MHC class II expression is sufficient to abrogate autoreactivity, INT IMMUNOL, 11(8), 1999, pp. 1295-1305
Authors:
de Bont, ESJM
Vellenga, E
Swaanenburg, JCJM
Fidler, V
Visser-van Brummen, PJ
Kamps, WA
Citation: Esjm. De Bont et al., Plasma IL-8 and IL-6 levels can be used to define a group with low risk ofsepticaemia among cancer patients with fever and neutropenia, BR J HAEM, 107(2), 1999, pp. 375-380
Risultati:
1-7
|